Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 97

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 97
---
center'>52</div>

Any litigation against NewGenIvf could be costly and time-consuming to defend and could harm its business, financial condition and results of operations.

NewGenIvf has in the
past and may in the future become subject to regulatory actions, litigation, disputes, or claims of various types, legal proceedings
and claims that arise in the ordinary course of business, such as claims brought by its clients or vendors in connection with
commercial disputes or employment claims made by its current or former employees, as well as claims brought by relevant regulatory
authorities or NewGenIvf’s competitors, patients, employees, or other third parties against NewGenIvf. NewGenIvf is unable to
predict the outcome of any of these legal proceedings. Such regulatory actions, disputes, allegations, complaints, or legal
proceedings may damage NewGenIvf’s reputation, evolve into litigation, or otherwise have a material adverse impact on
NewGenIvf’s reputation and business. Such proceedings might result in substantial costs, regardless of the outcome, and may
significantly divert management’s attention and resources from operating NewGenIvf’s business, which might seriously
harm its business, financial condition and results of operations. Insurance might not cover such claims, might not provide
sufficient payments to cover all the costs to resolve one or more such claims, and might not continue to be available on terms
acceptable to it. A claim brought against it that is uninsured or underinsured could result in unanticipated costs, potentially
harming its business, financial condition and results of operations. The outcomes of actions NewGenIvf institutes may not be
successful or favorable to NewGenIvf. Lawsuits against NewGenIvf may also generate negative publicity that significantly harms
NewGenIvf’s reputation, which may adversely affect NewGenIvf’s client base. NewGenIvf may also need to pay damages or
settle lawsuits with a substantial amount of cash.

Acquisitions, strategic investments, partnerships, or alliances could be difficult to identify, pose integration challenges, divert the attention of management, disrupt NewGenIvf’s business, dilute stockholder value, and adversely affect its business, financial condition and results of operations.

NewGenIvf may in the future
seek to acquire or invest in businesses, joint ventures, products and services, or technologies that it believes could complement or expand
its platform, enhance its technical capabilities, or otherwise offer growth opportunities. Any such acquisition or investment may divert